簡易檢索 / 詳目顯示

研究生: 鄞志修
Chih-Hsiu Yin
論文名稱: 小鼠胚胎幹細胞誘導分化成為肝臟細胞之研究
Studies on Induction of Mouse Embryonic Stem Cells into Hepatocytes
指導教授: 朱一民
I-Ming Chu
吳文騰
Wen-Teng Wu
口試委員:
學位類別: 博士
Doctor
系所名稱: 工學院 - 化學工程學系
Department of Chemical Engineering
論文出版年: 2007
畢業學年度: 96
語文別: 中文
論文頁數: 112
中文關鍵詞: 胚胎幹細胞肝臟細胞分化胚體
外文關鍵詞: Embryonic stem cells, Hepatocytes, differentiation, Embryoid bodies
相關次數: 點閱:3下載:0
分享至:
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報
  •   胚胎幹細胞是取自於囊胚的細胞,具有「多能性(Pluripotent)」和「自我更新(Self-renewal)」的能力,能夠在體外增殖並分化出各種成體細胞。近年來,胚胎幹細胞已被證實能夠在體外誘導分化成為肝臟細胞,而且具有治療小鼠肝病的能力。由於小鼠模式的成功,我們可以預見在將來,人類將需要大規模生產肝臟細胞的製程。人類將可利用這種分化的肝臟細胞來治療肝臟疾病,還能用來作為藥物研發的篩選平台,加速新藥的開發。
      有鑑於未來在肝臟細胞上將有大量需求,本研究探討量產具有肝分化能力的小鼠胚體及誘導分化出高肝功能的肝臟細胞。首先在初步實驗中,建立小鼠胚胎幹細胞的培養方法。本研究採用的胚胎幹細胞株為D3,與不活化的小鼠初代胚胎纖維母細胞共同培養。進行肝分化時,則將小鼠胚胎幹細胞製成胚體,隨後在貼附培養中便會進行肝分化。為了鑑定肝分化,我們利用ELISA量測胚體的白蛋白產量,並利用Indocyanine green (ICG)染色,來證實胚胎幹細胞分化出成熟的肝臟細胞。
      「胚體形成(Embryoid body formation)」是讓胚胎幹細胞進入肝分化過程的重要步驟。然而,製造胚體也是生產上的瓶頸,因為傳統的胚體製造方法只能用於小規模的生產。為了解決製造胚體的問題,我們嘗試利用攪拌式生物反應器Spinner flask來生產具有肝分化能力的小鼠胚體。我們的實驗結果顯示,胚胎幹細胞在Spinner flask中能夠形成胚體。與懸滴法比較,Spinner flask所製造的胚體其大小較小,而且大小的變異性較大。這些胚體能夠在貼附培養進行肝分化,而且生長激素與誘導物質具有促進肝分化的效果。在白蛋白分泌或是肝基因表現上,Spinner flask所製造的胚體都與懸滴法所製造的胚體相似。因此,Spinner flask有潛力能作為製造胚體的系統,來供後續量產肝臟細胞。
      在生產高肝功能的肝臟細胞方面,我們採用一連串的實驗設計法來進行培養方法的改良。我們發現,肝分化培養液在培養第7天時添加最有助於胚體產生更多白蛋白,進一步證實肝分化培養液的Dexamethasone是促進肝分化的重要因子。我們的方法能夠獲得高白蛋白產量的肝臟細胞,其白蛋白產量可達到1.90 ± 0.20 pg/h•cell,而且,這種肝臟細胞同樣具有ICG的吸收及排放能力,這顯示這些細胞具有成熟的肝臟細胞特徵,RT-PCR也證實分化出來的肝臟細胞具有成熟的肝基表現。
      本研究利用攪拌式生物反應器,開發肝分化能力小鼠胚體的生產方法,並研究出更經濟的肝分化方法,在不使用生長激素的情況下,就能生產出具有高肝功能的肝臟細胞。本研究的成果將有助於再生醫學及醫藥開發的進步。


    Embryonic stem cells (ES cells), pluripotent and self-renewal, rised from blastocysts, are able to propagate their population and differentiate into various adult cells in vitro. In recent year, ES cells are demonstrated that they can be induced to differentiate into hepatocytes in vitro. Further, the ES cell-derived hepatocytes show therapeutical efficiency to remedy the mice with liver disease. Due to the success of using the mouse model, we expect that people might need a process to produce ES cell-derived hepatocytes in large-scale. The ES cell-derived hepatocytes would be used for treatment of liver disease. They would also be used for drug screening to improve the study of drug development.
    Base on the requirement of large quantity of hepatocytes in the future, we study the mass production of mouse embryoid bodies (EBs) with hepatic differentiation ability, and induction to differentiate the hepatocytes with high liver function. Initially, we established the cultivation method of mouse ES cells in preliminary study. The ES cell line D3, used in this study, was co-cultured with inactivated primary mouse embryonic fibroblasts. For hepatic differentiation, ES cells were formed EBs, and the hepatic differentiation was appeared in further attached culture. To demonstrate hepatic differentiation, we measured albumin production of EBs by ELISA. Staining by indocyanine green (ICG) was also used to demonstrate that ES cells could differentiate into mature hepatocytes.
    EB formation is an important step for hepatic differentiation of ES cells. However, production of EBs is a bottleneck of the production of ES cell-derived hepatocytes, because traditional EB formation methods are just used for small-scale EB production. To this end, we attempted to produce mouse EBs with hepatic differentiation ability by a stirred tank bioreactor, “spinner flask.” Our study showed that ES cells could form EBs in spinner flask. Compare to EBs formed by hanging drop method, EBs formed by spinner flask showed in smaller size and size variation. The EBs could also proceed to hepatic differentiation in an attached culture, and promoted by growth factors and inducers. We also observed that EBs formed by spinner flask were similar to that formed by hanging drops on albumin production and hepatic gene expression. Hence, spinner flask has the potential to be an EB formation system for further mass production of ES cell-derived hepatocytes
    In the production of ES cell-derived hepatocytes with high liver function, we refined the culture method via a series of experimental design studies. We observed that hepatocyte differentiation medium was suitable for EBs to produce more albumin at day 7 of cultivation. Further, we demonstrated that dexamethasone was the most important factor to improve hepatic differentiation. Our refined method could obtain the ES cell-derived hepatocytes with high albumin production reached to 1.90 ± 0.20 pg/h•cell. In addition, the ES cell-derived hepatocytes showed ICG uptake ability and mature hepatic gene expression.
    In conclusion, the present study examined production method of EBs with hepatic differentiation ability by a stirred tank bioreactor. A more economical hepatic differentiation method was also examined. We could produce ES cell-derived hepatocytes with high liver function without growth factor induction. The present study will benefit for the progress of regenerative medicine and drug development.

    摘要...........................................................I Abstract.....................................................III 誌謝...........................................................V 表目錄.........................................................X 圖目錄........................................................XI 第1章 緒論...................................................1 1.1. 前言...................................................1 1.1.1. 胚胎幹細胞的來源.......................................1 1.1.2. 胚胎幹細胞的研究進展...................................2 1.1.3. 肝臟細胞的用途.........................................4 1.1.4. 幹細胞作為肝臟細胞來源的優缺點比較.....................6 1.1.5. 胚胎幹細胞作為肝臟細胞來源的優缺點比較.................7 1.1.6. 胚胎幹細胞分化成肝臟細胞的方法.........................8 1.1.7. 促進胚胎幹細胞肝分化的物質及技術......................14 1.1.8. 胚胎幹細胞分化成為肝臟細胞的證據......................19 1.1.9. 胚胎幹細胞肝分化的應用進展............................23 1.1.10. 結語..................................................25 1.2. 研究目標及論文架構....................................26 第2章 材料與方法............................................28 2.1. 胞外間質披覆培養容器..................................28 2.1.1. 明膠披覆..............................................28 2.1.2. 第一型膠原蛋白披覆....................................28 2.2. 滋養層細胞製備........................................29 2.3. 胚胎幹細胞培養........................................29 2.4. 細胞活性檢驗..........................................30 2.5. 胚體製造..............................................31 2.5.1. 懸滴法製造胚體........................................31 2.5.2. Spinner flask製造胚體.................................31 2.6. 肝分化誘導............................................32 2.6.1. 利用生長激素誘導肝分化................................32 2.6.2. 改良肝分化誘導過程....................................33 2.7. 實驗設計與統計分析....................................34 2.8. 胚體大小量測..........................................35 2.9. 胚體細胞數量測........................................36 2.10. 白蛋白定量量測........................................36 2.11. 肝基因表現分析........................................38 2.11.1. RNA萃取...............................................39 2.11.2. RT-PCR分析基因表現....................................39 2.12. 特定細胞比例量測......................................40 2.12.1. 細胞取樣..............................................40 2.12.2. 染色過程..............................................42 2.12.3. 分析過程..............................................43 2.13. 白蛋白陽性細胞之白蛋白產量測量........................44 2.14. ICG吸收和白蛋白蛋白質表現之雙重染色...................44 2.14.1. ICG染色...............................................44 2.14.2. ICG及白蛋白蛋白質表現之雙重染色.......................45 第3章 胚胎幹細胞培養和肝分化誘導............................46 3.1. 背景簡介..............................................46 3.1.1. 胚胎幹細胞的培養......................................46 3.1.2. 誘導胚胎幹細胞進行肝分化..............................47 3.1.3. 胚胎幹細胞肝分化的鑑定方法............................48 3.1.4. 研究目的..............................................48 3.2. 實驗結果..............................................49 3.2.1. 建立小鼠胚胎幹細胞的培養方法..........................49 3.2.2. 誘導胚胎幹細胞進行肝分化..............................51 3.2.3. 胚胎幹細胞的肝分化鑑定................................55 3.3. 討論..................................................58 第4章 量產具有肝分化能力的小鼠胚體..........................60 4.1. 背景簡介..............................................60 4.1.1. 小規模生產胚體的方法..................................60 4.1.2. 大規模生產胚體的方法..................................62 4.1.3. 研究目的..............................................63 4.2. 實驗結果..............................................64 4.2.1. 胚體形態及胚體大小....................................64 4.2.2. 胚體在肝分化過程產生白蛋白............................68 4.2.3. 胚體產生白蛋白的能力..................................70 4.2.4. 胚體大小對胚體白蛋白總產量的影響......................72 4.2.5. 肝基因表現............................................74 4.3. 討論..................................................76 第5章 生產高白蛋白產量的肝臟細胞............................78 5.1. 背景簡介..............................................78 5.1.1. 白蛋白的功能..........................................78 5.1.2. 促進胚胎幹細胞進行肝分化的方法........................79 5.1.3. 研究目的..............................................79 5.2. 實驗結果..............................................81 5.2.1. 尋找最佳的培養液更換時間..............................81 5.2.2. 基礎培養液、Dexamethasone和ITS對胚體產生白蛋白的影響..83 5.2.3. Insulin、Transferrin和Selenium對胚體產生白蛋白的影響..84 5.2.4. 分化的肝臟細胞之特性分析..............................85 5.3. 討論..................................................90 第6章 結論與未來展望........................................93 6.1. 結論..................................................93 6.2. 未來展望..............................................94 參考文獻......................................................96 作者簡介.....................................................111

    Abe K, Niwa H, Iwase K, Takiguchi M, Mori M, Abe SI, Yamamura KI. 1996. Endoderm-specific gene expression in embryonic stem cells differentiated to embryoid bodies. Exp Cell Res 229(1):27-34.
    Abu-Absi SF, Hu WS, Hansen LK. 2005. Dexamethasone effects on rat hepatocyte spheroid formation and function. Tissue Eng 11(3-4):415-26.
    Aejaz HM, Aleem AK, Parveen N, Khaja MN, Narusu ML, Habibullah CM. 2007. Stem cell therapy-present status. Transplant Proc 39(3):694-9.
    Allen JW, Hassanein T, Bhatia SN. 2001. Advances in bioartificial liver devices. Hepatology 34(3):447-55.
    Amit M, Carpenter MK, Inokuma MS, Chiu CP, Harris CP, Waknitz MA, Itskovitz-Eldor J, Thomson JA. 2000. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol 227(2):271-8.
    Amit M, Itskovitz-Eldor J. 2002. Derivation and spontaneous differentiation of human embryonic stem cells. J Anat 200(Pt 3):225-32.
    Arterburn LM, Zurlo J, Yager JD, Overton RM, Heifetz AH. 1995. A morphological study of differentiated hepatocytes in vitro. Hepatology 22(1):175-87.
    Asahina K, Fujimori H, Shimizu-Saito K, Kumashiro Y, Okamura K, Tanaka Y, Teramoto K, Arii S, Teraoka H. 2004. Expression of the liver-specific gene Cyp7a1 reveals hepatic differentiation in embryoid bodies derived from mouse embryonic stem cells. Genes Cells 9(12):1297-308.
    Baccarani U, Adani GL, Sainz M, Donini A, Risaliti A, Bresadola F. 2005. Human hepatocyte transplantation for acute liver failure: state of the art and analysis of cell sources. Transplant Proc 37(6):2702-4.
    Baharvand H, Hashemi SM, Kazemi Ashtiani S, Farrokhi A. 2006. Differentiation of human embryonic stem cells into hepatocytes in 2D and 3D culture systems in vitro. Int J Dev Biol 50(7):645-52.
    Bayliss MK, Cross DM. 2000. The importance of hepatocytes in drug metabolism studies: an industrial perspective. In: Berry MN, Edwards AM, editors. The hepatocyte review. Netherlands: Kluwer Academic Publishers. p 365-389.
    Bedossa P, Paradis V. 2003. Liver extracellular matrix in health and disease. J Pathol 200(4):504-15.
    Berthiaume F, Moghe PV, Toner M, Yarmush ML. 1996. Effect of extracellular matrix topology on cell structure, function, and physiological responsiveness: hepatocytes cultured in a sandwich configuration. Faseb J 10(13):1471-84.
    Bin Z, Sheng LG, Gang ZC, Hong J, Jun C, Bo Y, Hui S. 2006. Efficient cardiomyocyte differentiation of embryonic stem cells by bone morphogenetic protein-2 combined with visceral endoderm-like cells. Cell Biol Int 30(10):769-76.
    Bishop AE, Buttery LD, Polak JM. 2002. Embryonic stem cells. J Pathol 197(4):424-9.
    Bremer S, Hartung T. 2004. The use of embryonic stem cells for regulatory developmental toxicity testing in vitro--the current status of test development. Curr Pharm Des 10(22):2733-47.
    Cabrita GJ, Ferreira BS, da Silva CL, Goncalves R, Almeida-Porada G, Cabral JM. 2003. Hematopoietic stem cells: from the bone to the bioreactor. Trends Biotechnol 21(5):233-40.
    Cai J, Zhao Y, Liu Y, Ye F, Song Z, Qin H, Meng S, Chen Y, Zhou R, Song X and others. 2007. Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology 45(5):1229-39.
    Cameron CM, Hu WS, Kaufman DS. 2006. Improved development of human embryonic stem cell-derived embryoid bodies by stirred vessel cultivation. Biotechnol Bioeng 94(5):938-48.
    Chang KH, Zandstra PW. 2004. Quantitative screening of embryonic stem cell differentiation: endoderm formation as a model. Biotechnol Bioeng 88(3):287-98.
    Chinzei R, Tanaka Y, Shimizu-Saito K, Hara Y, Kakinuma S, Watanabe M, Teramoto K, Arii S, Takase K, Sato C and others. 2002. Embryoid-body cells derived from a mouse embryonic stem cell line show differentiation into functional hepatocytes. Hepatology 36(1):22-9.
    Choi D, Oh HJ, Chang UJ, Koo SK, Jiang JX, Hwang SY, Lee JD, Yeoh GC, Shin HS, Lee JS and others. 2002. In vivo differentiation of mouse embryonic stem cells into hepatocytes. Cell Transplant 11(4):359-68.
    Cross DM, Bayliss MK. 2000. A commentary on the use of hepatocytes in drug metabolism studies during drug discovery and development. Drug Metab Rev 32(2):219-40.
    Dang SM, Gerecht-Nir S, Chen J, Itskovitz-Eldor J, Zandstra PW. 2004. Controlled, scalable embryonic stem cell differentiation culture. Stem Cells 22(3):275-82.
    Dang SM, Kyba M, Perlingeiro R, Daley GQ, Zandstra PW. 2002. Efficiency of embryoid body formation and hematopoietic development from embryonic stem cells in different culture systems. Biotechnol Bioeng 78(4):442-53.
    Dasgupta A, Hughey R, Lancin P, Larue L, Moghe PV. 2005. E-cadherin synergistically induces hepatospecific phenotype and maturation of embryonic stem cells in conjunction with hepatotrophic factors. Biotechnol Bioeng 92(3):257-66.
    Desbaillets I, Ziegler U, Groscurth P, Gassmann M. 2000. Embryoid bodies: an in vitro model of mouse embryogenesis. Exp Physiol 85(6):645-51.
    Doetschman TC, Eistetter H, Katz M, Schmidt W, Kemler R. 1985. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol 87:27-45.
    Dvash T, Ben-Yosef D, Eiges R. 2006. Human embryonic stem cells as a powerful tool for studying human embryogenesis. Pediatr Res 60(2):111-7.
    Dzurinko VL, Gurwood AS, Price JR. 2004. Intravenous and indocyanine green angiography. Optometry 75(12):743-55.
    Ehashi T, Miyoshi H, Ohshima N. 2005. Oncostatin M stimulates proliferation and functions of mouse fetal liver cells in three-dimensional cultures. J Cell Physiol 202(3):698-706.
    Evans MJ, Kaufman MH. 1981. Establishment in culture of pluripotential cells from mouse embryos. Nature 292(5819):154-6.
    Fair JH, Cairns BA, Lapaglia M, Wang J, Meyer AA, Kim H, Hatada S, Smithies O, Pevny L. 2003. Induction of hepatic differentiation in embryonic stem cells by co-culture with embryonic cardiac mesoderm. Surgery 134(2):189-96.
    Fox IJ, Roy-Chowdhury J. 2004. Hepatocyte transplantation. J Hepatol 40(6):878-86.
    Gerecht-Nir S, Cohen S, Itskovitz-Eldor J. 2004. Bioreactor cultivation enhances the efficiency of human embryoid body (hEB) formation and differentiation. Biotechnol Bioeng 86(5):493-502.
    Gomez-Lechon MJ, Donato MT, Castell JV, Jover R. 2003. Human hepatocytes as a tool for studying toxicity and drug metabolism. Curr Drug Metab 4(4):292-312.
    Gouon-Evans V, Boussemart L, Gadue P, Nierhoff D, Koehler CI, Kubo A, Shafritz DA, Keller G. 2006. BMP-4 is required for hepatic specification of mouse embryonic stem cell-derived definitive endoderm. Nat Biotechnol 24(11):1402-11.
    Greenwel P, Rojkind M. The extracellular matrix of the liver. In: Arias IM, editor. The liver: Biology and pathobiology: Lippincott Williams & Wilkins. p 469-474.
    Hamazaki T, Iiboshi Y, Oka M, Papst PJ, Meacham AM, Zon LI, Terada N. 2001. Hepatic maturation in differentiating embryonic stem cells in vitro. FEBS Lett 497(1):15-9.
    Hamazaki T, Oka M, Yamanaka S, Terada N. 2004. Aggregation of embryonic stem cells induces Nanog repression and primitive endoderm differentiation. J Cell Sci 117(Pt 23):5681-6.
    Hamazaki T, Terada N. 2003. In vitro differentiation of embryonic stem cells into hepatocytes. Methods Enzymol 365:277-87.
    Hay DC, Zhao D, Ross A, Mandalam R, Lebkowski J, Cui W. 2007. Direct differentiation of human embryonic stem cells to hepatocyte-like cells exhibiting functional activities. Cloning Stem Cells 9(1):51-62.
    Heo J, Factor VM, Uren T, Takahama Y, Lee JS, Major M, Feinstone SM, Thorgeirsson SS. 2006. Hepatic precursors derived from murine embryonic stem cells contribute to regeneration of injured liver. Hepatology 44(6):1478-86.
    Hu AB, Cai JY, Zheng QC, He XQ, Shan Y, Pan YL, Zeng GC, Hong A, Dai Y, Li LS. 2004. High-ratio differentiation of embryonic stem cells into hepatocytes in vitro. Liver Int 24(3):237-45.
    IHGSC. 2004. Finishing the euchromatic sequence of the human genome. Nature 431(7011):931-45.
    Imamura T, Cui L, Teng R, Johkura K, Okouchi Y, Asanuma K, Ogiwara N, Sasaki K. 2004. Embryonic stem cell-derived embryoid bodies in three-dimensional culture system form hepatocyte-like cells in vitro and in vivo. Tissue Eng 10(11-12):1716-24.
    Ishii T, Yasuchika K, Fujii H, Hoppo T, Baba S, Naito M, Machimoto T, Kamo N, Suemori H, Nakatsuji N and others. 2005. In vitro differentiation and maturation of mouse embryonic stem cells into hepatocytes. Exp Cell Res 309(1):68-77.
    Ishizaka S, Shiroi A, Kanda S, Yoshikawa M, Tsujinoue H, Kuriyama S, Hasuma T, Nakatani K, Takahashi K. 2002. Development of hepatocytes from ES cells after transfection with the HNF-3beta gene. Faseb J 16(11):1444-6.
    Jacob M, Conzen P, Finsterer U, Krafft A, Becker BF, Rehm M. 2007. Technical and physiological background of plasma volume measurement with indocyanine green: a clarification of misunderstandings. J Appl Physiol 102(3):1235-42.
    Jefferson DM, Reid LM, Giambrone MA, Shafritz DA, Zern MA. 1985. Effects of dexamethasone on albumin and collagen gene expression in primary cultures of adult rat hepatocytes. Hepatology 5(1):14-20.
    Jochheim A, Hillemann T, Kania G, Scharf J, Attaran M, Manns MP, Wobus AM, Ott M. 2004. Quantitative gene expression profiling reveals a fetal hepatic phenotype of murine ES-derived hepatocytes. Int J Dev Biol 48(1):23-9.
    Jones EA, Tosh D, Wilson DI, Lindsay S, Forrester LM. 2002. Hepatic differentiation of murine embryonic stem cells. Exp Cell Res 272(1):15-22.
    Jung J, Zheng M, Goldfarb M, Zaret KS. 1999. Initiation of mammalian liver development from endoderm by fibroblast growth factors. Science 284(5422):1998-2003.
    Kallos MS, Sen A, Behie LA. 2003. Large-scale expansion of mammalian neural stem cells: a review. Med Biol Eng Comput 41(3):271-82.
    Kamiya A, Kinoshita T, Miyajima A. 2001. Oncostatin M and hepatocyte growth factor induce hepatic maturation via distinct signaling pathways. FEBS Lett 492(1-2):90-4.
    Kanda S, Shiroi A, Ouji Y, Birumachi J, Ueda S, Fukui H, Tatsumi K, Ishizaka S, Takahashi Y, Yoshikawa M. 2003. In vitro differentiation of hepatocyte-like cells from embryonic stem cells promoted by gene transfer of hepatocyte nuclear factor 3 beta. Hepatol Res 26(3):225-231.
    Kania G, Blyszczuk P, Czyz J, Navarrete-Santos A, Wobus AM. 2003. Differentiation of mouse embryonic stem cells into pancreatic and hepatic cells. Methods Enzymol 365:287-303.
    Kania G, Blyszczuk P, Jochheim A, Ott M, Wobus AM. 2004. Generation of glycogen- and albumin-producing hepatocyte-like cells from embryonic stem cells. Biol Chem 385(10):943-53.
    Keller GM. 1995. In vitro differentiation of embryonic stem cells. Curr Opin Cell Biol 7(6):862-9.
    Kelm JM, Timmins NE, Brown CJ, Fussenegger M, Nielsen LK. 2003. Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. Biotechnol Bioeng 83(2):173-80.
    Kinoshita T, Miyajima A. 2002. Cytokine regulation of liver development. Biochim Biophys Acta 1592(3):303-12.
    Kinoshita T, Sekiguchi T, Xu MJ, Ito Y, Kamiya A, Tsuji K, Nakahata T, Miyajima A. 1999. Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis. Proc Natl Acad Sci U S A 96(13):7265-70.
    Kitajima H, Yoshimura S, Kokuzawa J, Kato M, Iwama T, Motohashi T, Kunisada T, Sakai N. 2005. Culture method for the induction of neurospheres from mouse embryonic stem cells by coculture with PA6 stromal cells. J Neurosci Res 80(4):467-74.
    Koestenbauer S, Zech NH, Juch H, Vanderzwalmen P, Schoonjans L, Dohr G. 2006. Embryonic stem cells: similarities and differences between human and murine embryonic stem cells. Am J Reprod Immunol 55(3):169-80.
    Kuai XL, Cong XQ, Li XL, Xiao SD. 2003. Generation of hepatocytes from cultured mouse embryonic stem cells. Liver Transpl 9(10):1094-9.
    Kubo A, Shinozaki K, Shannon JM, Kouskoff V, Kennedy M, Woo S, Fehling HJ, Keller G. 2004. Development of definitive endoderm from embryonic stem cells in culture. Development 131(7):1651-62.
    Kulkarni JS, Khanna A. 2006. Functional hepatocyte-like cells derived from mouse embryonic stem cells: a novel in vitro hepatotoxicity model for drug screening. Toxicol In Vitro 20(6):1014-22.
    Kumashiro Y, Asahina K, Ozeki R, Shimizu-Saito K, Tanaka Y, Kida Y, Inoue K, Kaneko M, Sato T, Teramoto K and others. 2005. Enrichment of hepatocytes differentiated from mouse embryonic stem cells as a transplantable source. Transplantation 79(5):550-7.
    Lavon N, Yanuka O, Benvenisty N. 2004. Differentiation and isolation of hepatic-like cells fsrom human embryonic stem cell. Differentiation 72(5):230-8.
    Lee KD, Kuo TK, Whang-Peng J, Chung YF, Lin CT, Chou SH, Chen JR, Chen YP, Lee OK. 2004. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 40(6):1275-84.
    Lee LA. 2001. Advances in hepatocyte transplantation: a myth becomes reality. J Clin Invest 108(3):367-9.
    Maguire T, Novik E, Schloss R, Yarmush M. 2006. Alginate-PLL microencapsulation: Effect on the differentiation of embryonic stem cells into hepatocytes. Biotechnol Bioeng 93(3):581-91.
    Magyar JP, Nemir M, Ehler E, Suter N, Perriard JC, Eppenberger HM. 2001. Mass production of embryoid bodies in microbeads. Ann N Y Acad Sci 944:135-43.
    Mallon BS, Park KY, Chen KG, Hamilton RS, McKay RD. 2006. Toward xeno-free culture of human embryonic stem cells. Int J Biochem Cell Biol 38(7):1063-75.
    Maltsev VA, Wobus AM, Rohwedel J, Bader M, Hescheler J. 1994. Cardiomyocytes differentiated in vitro from embryonic stem cells developmentally express cardiac-specific genes and ionic currents. Circ Res 75(2):233-44.
    Martin MJ, Muotri A, Gage F, Varki A. 2005. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med 11(2):228-32.
    McNeish J. 2004. Embryonic stem cells in drug discovery. Nat Rev Drug Discov 3(1):70-80.
    Mitaka T. 1998. The current status of primary hepatocyte culture. Int J Exp Pathol 79(6):393-409.
    Mitry RR, Hughes RD, Dhawan A. 2002. Progress in human hepatocytes: isolation, culture & cryopreservation. Semin Cell Dev Biol 13(6):463-7.
    Miyashita H, Suzuki A, Fukao K, Nakauchi H, Taniguchi H. 2002. Evidence for hepatocyte differentiation from embryonic stem cells in vitro. Cell Transplant 11(5):429-34.
    Monga SP, Hout MS, Baun MJ, Micsenyi A, Muller P, Tummalapalli L, Ranade AR, Luo JH, Strom SC, Gerlach JC. 2005. Mouse fetal liver cells in artificial capillary beds in three-dimensional four-compartment bioreactors. Am J Pathol 167(5):1279-92.
    Monostory K, Kohalmy K, Prough RA, Kobori L, Vereczkey L. 2005. The effect of synthetic glucocorticoid, dexamethasone on CYP1A1 inducibility in adult rat and human hepatocytes. FEBS Lett 579(1):229-35.
    Novik EI, Maguire TJ, Orlova K, Schloss RS, Yarmush ML. 2006. Embryoid body-mediated differentiation of mouse embryonic stem cells along a hepatocyte lineage: insights from gene expression profiles. Tissue Eng 12(6):1515-25.
    Ogawa S, Tagawa Y, Kamiyoshi A, Suzuki A, Nakayama J, Hashikura Y, Miyagawa S. 2005. Crucial roles of mesodermal cell lineages in a murine embryonic stem cell-derived in vitro liver organogenesis system. Stem Cells 23(7):903-13.
    Orkin SH. 1996. Development of the hematopoietic system. Curr Opin Genet Dev 6(5):597-602.
    Park JK, Lee DH. 2005. Bioartificial liver systems: current status and future perspective. J Biosci Bioeng 99(4):311-9.
    Pascher A, Sauer IM, Hammer C, Gerlach JC, Neuhaus P. 2002. Extracorporeal liver perfusion as hepatic assist in acute liver failure: a review of world experience. Xenotransplantation 9(5):309-24.
    Peshwa MV, Wu FJ, Follstad BD, Cerra FB, Hu WS. 1994. Kinetics of hepatocyte spheroid formation. Biotechnol prog 10:460-466.
    Popp FC, Slowik P, Eggenhofer E, Renner P, Lang SA, Stoeltzing O, Geissler EK, Piso P, Schlitt HJ, Dahlke MH. 2007. No contribution of multipotent mesenchymal stromal cells to liver regeneration in a rat model of prolonged hepatic injury. Stem Cells 25(3):639-45.
    Preston SL, Alison MR, Forbes SJ, Direkze NC, Poulsom R, Wright NA. 2003. The new stem cell biology: something for everyone. Mol Pathol 56(2):86-96.
    Rambhatla L, Carpenter MK; 2001. Hepatocyte lineage cells derived from pluripotent stem cells. Patent WO01/81549A2.
    Rambhatla L, Carpenter MK; 2003. Hepatocyte lineage cells derived from pluripotent stem cells. Patent US6506574.
    Rambhatla L, Chiu CP, Kundu P, Peng Y, Carpenter MK. 2003. Generation of hepatocyte-like cells from human embryonic stem cells. Cell Transplant 12(1):1-11.
    Rands GF. 1986. Size regulation in the mouse embryo. II. The development of half embryos. J Embryol Exp Morphol 98:209-17.
    Reid LM, Fiorino AS, Sigal SH, Brill S, Holst PA. 1992. Extracellular matrix gradients in the space of Disse: relevance to liver biology. Hepatology 15(6):1198-203.
    Roncero C, Fabregat I, Benito M. 1995. Regulation of gene expression by interleukin-6 in fetal rat hepatocyte primary cultures: role of epidermal growth factor and dexamethasone. Hepatology 22(6):1769-75.
    Rossi JM, Dunn NR, Hogan BL, Zaret KS. 2001. Distinct mesodermal signals, including BMPs from the septum transversum mesenchyme, are required in combination for hepatogenesis from the endoderm. Genes Dev 15(15):1998-2009.
    Ruhnke M, Ungefroren H, Zehle G, Bader M, Kremer B, Fandrich F. 2003. Long-term culture and differentiation of rat embryonic stem cell-like cells into neuronal, glial, endothelial, and hepatic lineages. Stem Cells 21(4):428-36.
    Saito K, Yoshikawa M, Ouji Y, Moriya K, Nishiofuku M, Ueda S, Hayashi N, Ishizaka S, Fukui H. 2006. Promoted differentiation of cynomolgus monkey ES cells into hepatocyte-like cells by co-culture with mouse fetal liver-derived cells. World J Gastroenterol 12(42):6818-27.
    Sakai Y, Jiang J, Kojima N, Kinoshita T, Miyajima A. 2002. Enhanced in vitro maturation of fetal mouse liver cells with oncostatin M, nicotinamide, and dimethyl sulfoxide. Cell Transplant 11(5):435-41.
    Sauer IM, Obermeyer N, Kardassis D, Theruvath T, Gerlach JC. 2001. Development of a hybrid liver support system. Ann N Y Acad Sci 944:308-19.
    Schechter DC, Nealon TF, Jr., Gibbon JH, Jr. 1958. A simple extracorporeal device for reducing elevated blood ammonia levels; preliminary report. Surgery 44(5):892-7.
    Schmidt C, Bladt F, Goedecke S, Brinkmann V, Zschiesche W, Sharpe M, Gherardi E, Birchmeier C. 1995. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 373(6516):699-702.
    Schrem H, Klempnauer J, Borlak J. 2002. Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression. Pharmacol Rev 54(1):129-58.
    Schwartz RE, Linehan JL, Painschab MS, Hu WS, Verfaillie CM, Kaufman DS. 2005. Defined conditions for development of functional hepatic cells from human embryonic stem cells. Stem Cells Dev 14(6):643-55.
    Schwartz RE, Reyes M, Koodie L, Jiang Y, Blackstad M, Lund T, Lenvik T, Johnson S, Hu WS, Verfaillie CM. 2002. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest 109(10):1291-302.
    Sharma NS, Shikhanovich R, Schloss R, Yarmush ML. 2006. Sodium butyrate-treated embryonic stem cells yield hepatocyte-like cells expressing a glycolytic phenotype. Biotechnol Bioeng 94(6):1053-63.
    Shelly LL, Yeoh GC. 1991. Effects of dexamethasone and cAMP on tyrosine aminotransferase expression in cultured fetal rat hepatocytes. Eur J Biochem 199(2):475-81.
    Shirahashi H, Wu J, Yamamoto N, Catana A, Wege H, Wager B, Okita K, Zern MA. 2004. Differentiation of human and mouse embryonic stem cells along a hepatocyte lineage. Cell Transplant 13(3):197-211.
    Soars MG, McGinnity DF, Grime K, Riley RJ. 2007. The pivotal role of hepatocytes in drug discovery. Chem Biol Interact 168(1):2-15.
    Soto-Gutierrez A, Kobayashi N, Rivas-Carrillo JD, Navarro-Alvarez N, Zhao D, Okitsu T, Noguchi H, Basma H, Tabata Y, Chen Y and others. 2006a. Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes. Nat Biotechnol 24(11):1412-9.
    Soto-Gutierrez A, Navarro-Alvarez N, Rivas-Carrillo JD, Chen Y, Yamatsuji T, Tanaka N, Kobayashi N. 2006b. Differentiation of human embryonic stem cells to hepatocytes using deleted variant of HGF and poly-amino-urethane-coated nonwoven polytetrafluoroethylene fabric. Cell Transplant 15(4):335-41.
    Strain AJ, Neuberger JM. 2002. A bioartificial liver--state of the art. Science 295(5557):1005-9.
    Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, Wiltshire T, Orth AP, Vega RG, Sapinoso LM, Moqrich A and others. 2002. Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci U S A 99(7):4465-70.
    Tanaka Y, Yoshikawa M, Kobayashi Y, Kuroda M, Kaito M, Shiroi A, Yamao J, Fukui H, Ishizaka S, Adachi Y. 2003. Expressions of hepatobiliary organic anion transporters and bilirubin-conjugating enzyme in differentiating embryonic stem cells. Biochem Biophys Res Commun 309(2):324-30.
    Tangvoranuntakul P, Gagneux P, Diaz S, Bardor M, Varki N, Varki A, Muchmore E. 2003. Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid. Proc Natl Acad Sci U S A 100(21):12045-50.
    Teratani T, Yamamoto H, Aoyagi K, Sasaki H, Asari A, Quinn G, Sasaki H, Terada M, Ochiya T. 2005. Direct hepatic fate specification from mouse embryonic stem cells. Hepatology 41(4):836-46.
    Thomson H. 2007. Bioprocessing of embryonic stem cells for drug discovery. Trends Biotechnol 25(5):224-30.
    Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. 1998. Embryonic stem cell lines derived from human blastocysts. Science 282(5391):1145-7.
    Tsukada H, Takada T, Shiomi H, Torii R, Tani T. 2006. Acidic fibroblast growth factor promotes hepatic differentiation of monkey embryonic stem cells. In Vitro Cell Dev Biol Anim 42(3-4):83-8.
    Tsutsui M, Ogawa S, Inada Y, Tomioka E, Kamiyoshi A, Tanaka S, Kishida T, Nishiyama M, Murakami M, Kuroda J and others. 2006. Characterization Of Cytochrome P450 Expression In Murine Embryonic Stem Cell-Derived Hepatic Tissue System. Drug Metab Dispos.
    van Schaftingen E, Gerin I. 2002. The glucose-6-phosphatase system. Biochem J 362(Pt 3):513-32.
    Vassilopoulos G, Wang PR, Russell DW. 2003. Transplanted bone marrow regenerates liver by cell fusion. Nature 422(6934):901-4.
    Wagers AJ, Sherwood RI, Christensen JL, Weissman IL. 2002. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 297(5590):2256-9.
    Wartenberg M, Gunther J, Hescheler J, Sauer H. 1998. The embryoid body as a novel in vitro assay system for antiangiogenic agents. Lab Invest 78(10):1301-14.
    Wobus AM, Boheler KR. 2005. Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol Rev 85(2):635-78.
    Wu FJ, Friend JR, Hsiao CC, Zilliox MJ, Ko W, Cerra FB, Hu WS. 1996. Efficient assembly of rat hepatocyte spheroids for tissue engineering applications. Biotechnol Bioeng 50:404-415.
    Yamada T, Yoshikawa M, Kanda S, Kato Y, Nakajima Y, Ishizaka S, Tsunoda Y. 2002. In vitro differentiation of embryonic stem cells into hepatocyte-like cells identified by cellular uptake of indocyanine green. Stem Cells 20(2):146-54.
    Yamamoto H, Quinn G, Asari A, Yamanokuchi H, Teratani T, Terada M, Ochiya T. 2003. Differentiation of embryonic stem cells into hepatocytes: biological functions and therapeutic application. Hepatology 37(5):983-93.
    Yamamoto Y, Teratani T, Yamamoto H, Quinn G, Murata S, Ikeda R, Kinoshita K, Matsubara K, Kato T, Ochiya T. 2005. Recapitulation of in vivo gene expression during hepatic differentiation from murine embryonic stem cells. Hepatology 42(3):558-67.
    Yin CH, Chen W, Hsiao CC, Kuo CY, Chen CL, Wu WT. 2007. Production of mouse embryoid bodies with hepatic differentiation potential by stirred tank bioreactor. Biosci Biotechnol Biochem 71(3):728-34.
    Yin Y, Lim YK, Salto-Tellez M, Ng SC, Lin CS, Lim SK. 2002. AFP(+), ESC-derived cells engraft and differentiate into hepatocytes in vivo. Stem Cells 20(4):338-46.
    Zaret KS. 2001. Hepatocyte differentiation: from the endoderm and beyond. Curr Opin Genet Dev 11(5):568-74.
    Zaret KS. 2002. Regulatory phases of early liver development: paradigms of organogenesis. Nat Rev Genet 3(7):499-512.
    Zhou QJ, Xiang LX, Shao JZ, Hu RZ, Lu YL, Yao H, Dai LC. 2007. In vitro differentiation of hepatic progenitor cells from mouse embryonic stem cells induced by sodium butyrate. J Cell Biochem 100(1):29-42.

    無法下載圖示 全文公開日期 本全文未授權公開 (校內網路)
    全文公開日期 本全文未授權公開 (校外網路)

    QR CODE